Literature DB >> 30678477

Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis.

Lana Meiqari1,2, Dirk Essink1, Pamela Wright3, Fedde Scheele1.   

Abstract

Studies on the prevalence of hypertension in Vietnam have reported various estimates. There is no up-to-date assessment of the evidence on the magnitude of hypertension in Vietnam. Search engines for scientific and gray literature were used to identify relevant records for eligibility screening and quality assessment. Data from selected articles were extracted using standardized spreadsheets. Statistical analysis included estimating pooled prevalence and odds ratio, heterogeneity evaluation, meta-regression, and subgroup analysis, in addition to sensitivity analysis and publication bias evaluation. The pooled prevalence of measured hypertension in Vietnam was 21.1% (95% confidence interval = 18.5-23.7) based on 10 studies, and 18.4% (95% confidence interval = 15.2-21.8) based on 3 national surveys. Lower pooled prevalence was estimated for hypertension awareness (9.3%) and hypertension treatment (4.7%). The pooled prevalence of measured hypertension is significantly higher among men. The pooled prevalence of measured hypertension and hypertension awareness and treatment were significantly lower in rural settings. There is a need to strengthen efforts for primary and secondary prevention and disease management to reduce morbidity and mortality, especially in rural residence settings.

Entities:  

Keywords:  Vietnam; awareness; hypertension; meta-analysis; prevalence; systematic review

Mesh:

Year:  2019        PMID: 30678477      PMCID: PMC6463272          DOI: 10.1177/1010539518824810

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


Introduction

Rationale

Noncommunicable diseases caused 72.3% of global deaths in 2016, with cardiovascular diseases (CVDs) representing the highest proportion of these deaths.[1] Primary hypertension (HTN) is one of the CVDs that is caused by different physiological and behavioral risk factors such as harmful use of alcohol, high body mass index, lead exposure, tobacco use, and a high-salt diet. Concurrently, high blood pressure (HBP) as a physiological risk factor contributes to a high burden of other noncommunicable diseases, for example, strokes and chronic kidney diseases.[2,3] While the burden of HTN is increasing globally,[1,4] low- and middle-income countries (LMICs) are enduring a higher burden due to their demographic, socioeconomic, urban, and/or epidemiological transitions.[5] Primary prevention for HTN/HBP is possible by managing its risk factors; besides, HBP/HTN can be considered a modifiable risk factor since its management and control are secondary prevention measures for associated complications.[6] Management of HBP/HTN includes promoting and supporting behavioral changes toward a more healthy living, in addition to treating and controlling through pharmacological interventions.[7] In LMICs, management and control efforts are more complicated due to their weak health systems and limited resources.[6,8] Vietnam established its national HTN program in 2008.[9] Since then, studies on the prevalence of HTN, including few national samples, have been published and varied in their estimates. In 2012, a time trends analysis for blood pressure was performed using a dataset compiled by multiple cross-sectional studies; the analysis showed a significant increase of HTN prevalence of 0.9% per year between 2001 and 2009.[10] There is no up-to-date assessment of the evidence on the magnitude of HTN in Vietnam. Consolidating available data in the literature into a national estimate of the prevalence of HTN is crucial to provide information for future policy regarding population need, management, and control of HTN in Vietnam.

Objectives

This article aims to perform a systematic review and a meta-analysis of the prevalence of HTN in Vietnam and its associated risk factors reported as relevant to the Vietnamese population, in addition to the prevalence of HTN awareness and treatment.

Methods

The reporting of this review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.[11]

Eligibility Criteria

Eligibility criteria for inclusion were community-based (ie, population-based) studies to detect hypertensive subjects among adult population (≥18 years) living in Vietnam. Study design could be cross-sectional or cohort. Exclusion criteria were the following: the population was refugees and migrants living outside Vietnam in addition to war veterans who are not Vietnamese; records that were abstracts, conference posters, reviews, and meta-analysis; articles reporting duplicated data; and studies that were facility-based or did not use random sampling.

Information Sources and Search Strategy

The following databases were searched: PubMed, EMBASE, CINAHL, and Web of Science (performed on October 13, 2017), in addition to gray literature (eg, governmental and international documents) through Google and relevant websites. The search terms incorporated a combination of keywords and index terms related to HTN (eg, CVDs, HTN, HBP) and the outcome (eg, prevalence, burden, morbidity, health need). Detailed tables on the search terms used are provided in Appendix 1 (all appendixes are available online). Furthermore, the reference lists of retrieved full-text records were searched to identify additional relevant records. The search strategy focused on records published in English; however, we reviewed relevant Vietnamese websites and documents to look for information on national surveys that might be only available in Vietnamese and not published in English.

Selection Process

One researcher (LM) screened the title and abstract using the Rayyan application.[12] Then, full-texts were retrieved for selected records and assessed again for their eligibility. Finally, quality assessment was performed during data extraction to make a final decision on record’s inclusion in the meta-analysis.

Data Extraction

The data extraction was done using standardized spreadsheets. Since one researcher (LM) was available to perform the data extraction, it was conducted twice within 1 month to compare the results between 2 separate time points.[13] The information extracted included (1) study characteristics: author, publication year, objective, project related to the study (if applicable), data collection year, location, sampling technique, sample size and response rate, HTN definition used, and type of statistical analysis and adjustment variables; (2) participants characteristics: age group targeted, mean age, proportions of women, and residence setting; and finally (3) outcome(s) of interest: number of hypertensive subjects in total and by risk factors categories, in addition to number of those aware of their HTN condition and/or treated.

Quality Assessment

Studies were assessed based on a checklist of 5 criteria covering both study and reporting qualities[14]; these criteria were also applicable for assessing the risk of bias at study level. The checklist included (1) appropriate sampling strategy, (2) response rate >80.0%, (3) clear procedures for blood pressure measurement including use of World Health Organization’s guidelines of STEPwise approach to surveillance of noncommunicable diseases[15] to develop study protocol or providing detailed information on type of blood pressure measurement device and number of readings taken to measure the outcome, (4) definition of HTN used is measured HTN at ≥140/90 mm Hg levels, and (5) at least one quality assurance method such as training of data collectors, pretesting, and supervision. High-quality studies (with a complete score of 5) were included for meta-analysis.

Operationalization of Summary Measures

Summary measures included the following: first, the prevalence of HTN; second, the prevalence of HTN awareness; third, the prevalence of HTN treatment; and fourth, factors associated with HTN and sex, expressed as a crude odds ratio (OR).

Statistical Analysis

The pooled prevalence was weighted by inverse variance method, with the use of Freeman-Tukey double arcsine transformation to stabilize the proportions calculated for each study. The pooled OR for the association between HTN and reported risk factors was calculated using Mantel-Haenszel method. Due to the expected heterogeneity among studies, DerSimonian-Laird random-effects model was used to compute the effect estimates; however, the forest plots included results of the fixed-effect model as well. Assessment of heterogeneity comprised calculating τ2 statistic and I2 statistic. Tau-squared statistic provides an estimate of the between-study variance, in which a value of >1.0 suggests the presence of substantial statistical heterogeneity. I-squared statistic provides an estimate of the percentage of the variability in effect estimate that is due to heterogeneity rather than sampling error or chance differences where values of 25.0%, 50.0%, and 75.0% are interpreted as low, medium, and high heterogeneity, respectively. The potential modifying effects of 7 study-level variables on the pooled prevalence of HTN were assessed using univariate mixed-effects meta-regression analyses and subgroup analysis. The included variables were data collection year, study publication year, use of STEPS protocols, type of used measurement device, proportion of women, youngest age group targeted, sample’s mean age, and residence settings. For subgroup differences, Cochran’s Q test (χ2) was performed, where significant P < .10 suggests evidence of heterogeneity. Sensitivity analyses were performed by removing studies with the smallest sample sizes and outlier results. Finally, publication bias to assess the risk of bias across studies was conducted by evaluating funnel plot asymmetry using Egger’s linear regression test and Begg’s rank correlation test, as significant P value suggests the presence of statistical publication bias. The results reported the pooled estimates with their 95% confidence interval (CI). CI for pooled prevalence was calculated using an “exact” binomial interval (ie, Clopper-Pearson interval). Significance was set at P < .05. The analysis was conducted using “meta” and “metafor” packages of R software.[16,17]

Results

Study Selection

There were 1319 records identified from the database search and 34 from the manual search (Figure 1). Of these, 429 were duplicates, and 857 were excluded based on “title and abstract” screening. After full-text assessment of the remaining 67 articles, 25 studies were found to be eligible.[18-42]
Figure 1.

Flow chart of records retrieved, screened and included in the systematic review and meta-analysis

Flow chart of records retrieved, screened and included in the systematic review and meta-analysis Of the 25 eligible studies, 15 studies (60.0%) did not meet all 5 quality criteria.[18,19,21,23,26,29,34-42] Excluded studies comprise 70.9% of overall participants because 2 national surveys had low response rate.[18,19] Ten studies, with a population of 44 941 subjects, were included in this meta-analysis.[20,20,22,24,25,27,28,30-33] Detailed tables on the quality assessment are available in Appendix 2.

Study Characteristics

An overview of the included articles is available in Table 1. All studies are population-based observational cross-sectional design. Seven studies focused on HTN as a primary outcome,[20,20,27,28,30-33] while the rest focused on other related diseases or risk factors and had HTN as a secondary outcome. There were 3 national studies that comprised 66.6% of total subjects[27,31,32]; the rest were conducted in 4 regions: North East (n = 2; 13.6% of total subjects), Red River Delta (n = 2; 8.9% of total subjects), North Central and Central Coastal Areas (n = 2; 5.8% of total subjects), and South East (n = 1; 5.0% of total subjects). Three studies had an equal proportion of females and males in their samples, while the rest had higher proportions for females. Three studies reported age categories only; the mean age reported from 10 studies was 48.1 ± 4.6. For further analysis regarding residence settings, the studies were classified using the following criteria: rural settings if they covered >75.0% rural residents (n = 5); urban settings if they covered ≤30.0% rural residents (n = 2); and mixed rural/urban settings (n = 3) where the proportion of rural residents ranged between 50.8% and 65.9%. Results of meta-analysis are shown in Table 2.
Table 1.

Study Characteristics.

#First Author, Year (Project)Data Collection YearStudy FocusProvince, RegionPopulationSampling TechniqueUse of STEPS ProtocolsSample Size, nResponse Rate, %Women, %Mean Age, nRural Residents, %Residence Setting
1Minh, 2006 (FilaBavi HDSS)2002HypertensionHanoi, Red River Delta25-64 yearsRandom selection from databaseYes199699.850.0NR 100.0 Rural
2Hoang, 2007 (FilaBavi HDSS)2005Risk factors of chronic diseasesHanoi, Red River Delta25-64 yearsRandom selection from databaseYes198499.250.3NR 100.0 Rural
3Ta, 2010NRType 2 diabetes mellitusHCMC, South East30-70 yearsRandom sample, with PPSNR233090.069.150.0 0.0 Urban
4Fitzpatrick, 20122010Risk factors and symptoms of strokeDa Nang, North Central, and Central Coastal Areas≥35 yearsMultistage clustered samplingYes162194.556.152.030.4Urban
5Son, 2012 (NESH, STEPS survey)2002-2008HypertensionNational, 8 provinces≥25 yearsMultistage stratified sampling[a]Yes982393.060.842.750.8Mixed
6Ha, 20132011HypertensionThai Nguyen, North East≥25 yearsMultistage stratified clustered, with PPS[a]NR234881.556.345.082.8Rural
7Nguyen, 20142012HypertensionThai Nguyen, North East35-64 yearsRandom sample in 4 communesNR377986.556.747.4 100.0 Rural
8Do, 2015 (NAOS)2005HypertensionNational, 8 provinces25-64 yearsMultistage stratified clustered, with PPS[a,b,c]Yes17 19997.050.744.276.4Rural
9Ministry of Health, 20162015HypertensionNational, 63 provinces18-69 yearsMultistage stratified clustered, with PPS[b,c]Yes259079.857.0NR55.2Mixed
10Hien, 20182015HypertensionThua Thien Hue, North Central, and Central Coastal Areas40-64 yearsMultistage clustered samplingYes96980.856.155.565.9Mixed

Abbreviations: STEPS, STEPwise approach to surveillance of noncommunicable diseases; FilaBavi HDSS, Health and Demographic Surveillance System at Ba Vi District, part of INDEPTH Network; NR, not reported; PPS, probability proportional to size; NESH, National Epidemiological Survey on Hypertension and Its Risk Factors; NAOS, National Adult Overweight Survey.

Stratified by geographical regions.

Stratified by age and sex strata.

Stratified by urban/rural settings.

Residence settings that are either totally rural or urban are indicated in bold.

Table 2.

Results of Meta-Analysis (Forest Plots Are Available in Appendices).

Prevalence of Measured Hypertension
Prevalence of Hypertension Awareness
Prevalence of Hypertension Treatment
k Pooled95% CIτ2 I 2 P * k Pooled95% CIτ2 I 2 P * k Pooled95% CIτ2 I 2 P *
Studies included in meta-analysis1021.118.523.70.002697.669.35.314.30.009499.474.72.67.30.005699.0
Studies with national samples318.415.221.80.001497.928.43.016.30.007599.734.81.99.00.005299.4
Subgroup analyses
Sex
 Men926.423.129.90.003395.9 <.01 510.35.815.90.008898.7.7355.12.78.20.005097.8.95
 Women916.613.420.00.004497.658.93.915.70.013899.355.02.09.10.008598.9
Mean age category
 <45 years220.016.423.90.001198.2 <.01 28.43.016.30.007599.7 <.01 24.71.110.60.006899.7 <.01
 45-48 years220.419.421.400.017.46.48.513.12.43.8
 50-56 years328.327.129.6<0.00010.9130.127.333.1114.912.717.2
 NR315.612.718.70.001391.924.31.19.40.005397.733.00.96.20.004797.7
Residence setting
 Mixed rural/urban321.915.728.90.004998.3 <.01 220.46.040.40.025299.4 .04 38.75.312.70.003397.5 <.01
 Rural518.116.120.30.000993.145.33.67.20.001695.642.41.53.60.001093.4
 Urban227.926.629.400.00—-0

Abbreviations: k, number of studies included in the meta-analysis of the pooled estimate; CI, confidence interval; τ2, a statistic provides an estimate of the between-study variance, in which a value of >1.0 suggests the presence of substantial statistical heterogeneity; I2, a statistic provides an estimate of the percentage of the variability in effect estimate that is due to heterogeneity rather than sampling error or chance differences where values of 25.0%, 50.0%, and 75.0% are interpreted as low, medium, and high heterogeneity, respectively; NR, not reported.

Test for subgroup differences, that is, Cochran’s Q test (χ2) where significant P < .10 suggests evidence of heterogeneity.

Significant p values are indicated in bold.

Study Characteristics. Abbreviations: STEPS, STEPwise approach to surveillance of noncommunicable diseases; FilaBavi HDSS, Health and Demographic Surveillance System at Ba Vi District, part of INDEPTH Network; NR, not reported; PPS, probability proportional to size; NESH, National Epidemiological Survey on Hypertension and Its Risk Factors; NAOS, National Adult Overweight Survey. Stratified by geographical regions. Stratified by age and sex strata. Stratified by urban/rural settings. Residence settings that are either totally rural or urban are indicated in bold. Results of Meta-Analysis (Forest Plots Are Available in Appendices). Abbreviations: k, number of studies included in the meta-analysis of the pooled estimate; CI, confidence interval; τ2, a statistic provides an estimate of the between-study variance, in which a value of >1.0 suggests the presence of substantial statistical heterogeneity; I2, a statistic provides an estimate of the percentage of the variability in effect estimate that is due to heterogeneity rather than sampling error or chance differences where values of 25.0%, 50.0%, and 75.0% are interpreted as low, medium, and high heterogeneity, respectively; NR, not reported. Test for subgroup differences, that is, Cochran’s Q test (χ2) where significant P < .10 suggests evidence of heterogeneity. Significant p values are indicated in bold.

Measured Hypertension

Forest plots are available in Appendix 3. The pooled prevalence of measured HTN for the 10 studies is 21.1% (95% CI = 18.5-23.7; τ2 = 0.0026; I2 = 98%). The pooled prevalence of measured HTN for the 3 national studies is 18.4% (95% CI = 15.2-21.8; τ2 = 0.0014; I2 = 98%). The results of the univariate meta-regression analyses showed that 3 factors significantly influenced the HTN prevalence and explained proportions of total between-study variance (ie, R2 statistic); these were proportions of women (QM = 7.8, degrees of freedom [df] = 1, P < .01, R2 = 31.8%), mean age (QM = 38.3, df = 3, P < .001, R2 = 67.1%), and residence setting (QM = 10.2, df = 2, P < .01, R2 = 29.5%). Nine studies reported on the number of hypertensive subjects disaggregated by sex. The pooled prevalence of HTN among men is 26.4% (95% CI = 23.1-29.9; τ2 = 0.0033; I2 = 96%), which is higher than the overall prevalence. However, the pooled prevalence of HTN among women was lower, equaling 16.6% (95% CI = 13.4-20.0; τ2 = 0.0044; I2 = 98%). The pooled prevalence of HTN among studies with a mean age ranging between 50 and 56 years is higher than the overall prevalence, equaling 28.3% (95% CI = 27.1-29.6; τ2 < 0.0001; I2 = 1%). With regard to residence settings, higher prevalence of HTN was found among studies undertaken in urban settings (27.9; 95% CI = 26.6-29.4; I2 = 0%) compared with mixed rural/urban settings (21.9%; 95% CI = 15.7-28.9; I2 = 98%) then rural settings (18.1%; 95% CI = 16.1-20.3; I2 = 93%).

Awareness of Hypertension

Forest plots are available in Appendix 4. Only 6 studies reported on the proportion of those aware of their HTN condition. The pooled prevalence of HTN awareness was 9.3% (95% CI = 5.3-14.3; τ2 = 0.0094; I2 = 99%). Awareness was significantly associated with age and residence. A significant higher proportion of HTN awareness was reported among studies with oldest age group and those conducted in mixed rural/urban settings (49.0%; 95% CI = 43.6-54.4; τ2 = 0.002; I2 = 89%) compared with rural settings (27.5%; 95% CI = 21.7-33.6; τ2 = 0.0041; I2 = 92%).

Treatment of Hypertension

Forest plots are available in Appendix 5. Only 7 studies reported on the proportion of those treated for their HTN condition. The pooled prevalence of HTN treatment was 4.7% (95% CI = 2.6-7.3; τ2 = 0.0056; I2 = 99%). Similar to prevalence of HTN awareness, a significant higher proportion of HTN treatment was reported among studies with oldest age group and those conducted in mixed rural/urban settings (8.7%; 95% CI = 5.3-12.7; τ2 = 0.0033; I2 = 98%) compared with rural settings (2.4%; 95% CI = 1.5-3.6; τ2 = 0.0010; I2 = 93%).

Factors Associated With the Pooled Prevalence and Sex

Data are available in Appendix 6. Men has substantially higher odds than women for measured HTN (OR = 1.8; 95% CI = 1.6-2.1), HTN awareness (OR = 1.8; 95% CI = 1.5-2.1), and HTN treatment (OR = 1.8; 95% CI = 1.6-2.1). When stratified by categories for mean age and residence settings, only 2 subgroup analyses are significant. The association between male sex and measured HTN was higher for one study with mean age category 45 to 48 years (OR = 2.3; 95% CI = 2.0-2.7; τ2 = 0.0205; I2 = 76%), while the association between male sex and HTN awareness was higher for studies conducted in rural settings (OR = 1.9; 95% CI = 1.8-2.1; τ2 = 0.00216; I2 = 80%) compared with mixed rural/urban settings (OR = 1.5; 95% CI = 1.3-1.7).

Heterogeneity, Sensitivity Analyses, and Publication Bias

The included studies in the analyses of the pooled estimates showed a high heterogeneity. As a result of the regression analyses, the heterogeneity decreased when stratifying by sex, mean age category, and residence settings. To further identify specific sources of heterogeneity, more analysis for the prevalence of HTN excluded studies based on their smaller sample size or outlier results. The pooled prevalence calculated after the removal of 5 studies remained within ±10% of the original estimate. No evidence of publication bias was found based on the funnel plot asymmetry tests for all 3 summary measures (funnel plots are available in Appendix 7).

Discussion

To the best of our knowledge, this is the most comprehensive systematic review and meta-analysis on HTN prevalence in Vietnam. The pooled estimate for the prevalence of measured HTN in Vietnam, based on 10 studies published between 2005 and 2018, is 21.1%. However, the pooled estimate for the 3 studies with national surveys was lower (18.4%). These national samples can be more representative and reliable since they cover 66.6% of the total surveyed population included in this meta-analysis. A meta-analysis on the prevalence of HTN in LMICs (2001-2015) found an overall prevalence of 32.3% (29.4-35.3) and 35.5% (32.2-39.4) in East Asia and Pacific, respectively, based on 33 articles from China (n = 22), Vietnam (n = 5, all included in our analysis), Malaysia (n = 4), Thailand (n = 1), and Federated States of Micronesia (n = 1).[5] Another meta-analysis for the prevalence of HTN in Chinese cities (2002-2010) had an estimate of 21.5% (19.4% to 23.6%).[43] Our estimate for the prevalence of HTN in Vietnam appears to be lower than estimates reported in other countries of East Asia and Pacific. One explanation may be the observed differences in conducting surveys and measurement procedures, which have either changed over time or have not followed one specific guideline. Additionally, while most studies used digital measurement devices, only 2 with one of the national studies have used mercury sphygmomanometer. However, the pooled prevalence was not significantly associated with the use of digital or mercury measurement device. Residence settings have significantly influenced the pooled prevalence of measured HTN and HTN awareness and treatment. There was a higher prevalence of measured HTN in urban and mixed rural/urban compared with separate rural settings; this is similar to findings from the meta-analysis of LMICs[5] and the time trends analysis of Vietnam.[10] Furthermore, the proportion of hypertensive subjects who are aware of their condition was significantly higher among mixed rural/urban compared with rural settings. The time trends analysis found an increased prevalence of HTN awareness in both rural and urban areas between 2001 and 2009; however, the change in HTN awareness in urban areas and HTN control in rural areas had slower progress.[10] Our results regarding the lower awareness of HTN in rural settings may reflect a limited detection of HTN in the rural areas of the country compared with urban areas. As expected, the odds of measured HTN among men was higher than the odds of HTN among women. This sex difference was also affected by residence settings with higher odds of HTN among men living in rural settings, while the overall prevalence for both sexes is higher in urban settings. This is an unusual pattern that was also reported in the individual studies. Further research may focus on explaining this sex difference in the prevalence of HTN in Vietnam. The quality assessment has excluded 2 national surveys[18,19] due to a low response rate. The data collection date for these 2 surveys was 2002 and 2009-2010, respectively. In addition, both studies had good sample sizes (n = 77 758 and n = 14 706, respectively). The 2 studies reported a lower overall prevalence of HTN; however, both studies showed a higher prevalence among men compared with women. Furthermore, the latest study[19] explored regional differences in the prevalence of HTN with the highest prevalence in West Highland (Dak Lak province) and Mekong River Delta (Can Tho province) and the lowest prevalence in Red River Delta (Ha Noi) and North Central (Hue). Our analysis could not look at regional differences because half the included studies are from 2 regions and the national ones did not report their data by region.

Strengths and Limitations

We reported results from only high-quality studies, and there was no evidence of publication bias. We also reported results for both random and fixed models, which showed similar results in pooled estimates; however, they differed in the 95% CIs. Heterogeneity among studies was high; its causes include differences in sample characteristics and standardization of blood pressure measurement procedures including devices and number of readings. Although we tried to lower the heterogeneity by conducting meta-regression and subgroup analysis, we were limited to the factors that could be included, especially with only 7 studies with a primary focus on HTN. For example, the age range was different in included studies; when stratifying by age groups, we had a smaller number of studies. Few studies reported on the awareness, treatment, and control of HTN. There was enough number of studies to perform an analysis on HTN awareness and treatment; a smaller number of studies reported estimates for control of HTN. The studies covered different parts of the country for both rural and urban populations. However, representation is questionable since some regions were only covered by the national surveys, with no individual studies conducted there.

Conclusion

Hypertension is a significant public health problem in Vietnam. Almost 1 in 5 people may have HTN. Awareness and treatment were much lower in rural areas. There is a need to strengthen primary and secondary prevention measures in addition to management activities to reduce morbidity and mortality of HTN, especially in rural areas. Click here for additional data file. Supplemental material, Appendix_1_Search_Strategy for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_2_Quality_Assessment_Final for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_3_Forest_Plot_Measured_HTN for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_4_Forest_Plot_HTN_Awareness for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_5_Forest_Plot_HTN_Treatment for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_6_OR_HTN_Sex for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health Click here for additional data file. Supplemental material, Appendix_7_Funnel_Plots for Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis by Lana Meiqari, Dirk Essink, Pamela Wright and Fedde Scheele in Asia Pacific Journal of Public Health
  35 in total

1.  Quality control in systematic reviews and meta-analyses.

Authors:  M J Bown; A J Sutton
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-08-21       Impact factor: 7.069

2.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

3.  Prevalence and risk factors for diabetes in Ho Chi Minh City, Vietnam.

Authors:  L N T Duc Son; K Kusama; N T K Hung; T T H Loan; N V Chuyen; D Kunii; T Sakai; S Yamamoto
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

4.  Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League.

Authors:  Xin H Zhang; Liu Lisheng; Norm R C Campbell; Mark L Niebylski; Peter Nilsson; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-08       Impact factor: 3.738

5.  Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam.

Authors:  Duc Anh Ha; Robert J Goldberg; Jeroan J Allison; Thang Hong Chu; Hoa L Nguyen
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

7.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

8.  Prevalence of hypertension in Chinese cities: a meta-analysis of published studies.

Authors:  Yu-Quan Ma; Wen-Hua Mei; Ping Yin; Xiao-Hui Yang; Sana Kiani Rastegar; Jian-Dong Yan
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

9.  Symptoms and risk factors for stroke in a community-based observational sample in Viet Nam.

Authors:  Annette L Fitzpatrick; Quang Van Ngo; Kiet A Ly; Thanh G N Ton; W T Longstreth; Tung T Vo; Kristen Heitzinger; Chien H Pham; David L Tirschwell
Journal:  J Epidemiol Glob Health       Date:  2012-09

10.  National survey of risk factors for non-communicable disease in Vietnam: prevalence estimates and an assessment of their validity.

Authors:  Tan Van Bui; Christopher Leigh Blizzard; Khue Ngoc Luong; Ngoc Le Van Truong; Bao Quoc Tran; Petr Otahal; Seana Gall; Mark R Nelson; Thuy Bich Au; Son Thai Ha; Hai Ngoc Phung; Mai Hoang Tran; Michele Callisaya; Velandai Srikanth
Journal:  BMC Public Health       Date:  2016-06-10       Impact factor: 3.295

View more
  11 in total

1.  Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk factors.

Authors:  Thuy Nguyen Thi Phuong; Trang Dao Thi; Ingrid E Lundberg; Binh Nguyen Huy
Journal:  Rheumatol Adv Pract       Date:  2022-06-02

Review 2.  Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis.

Authors:  Hassan Okati-Aliabad; Alireza Ansari-Moghaddam; Shiva Kargar; Mahdi Mohammadi
Journal:  J Hum Hypertens       Date:  2022-01-15       Impact factor: 2.877

3.  Socioeconomic differentials in trends in the prevalence of hypertension and pre-hypertension and hypertension awareness, treatment, and control in rural Southwestern China.

Authors:  Lu-Ming Fan; Fang Wang; Min Zhao; Wen-Long Cui; Le Cai
Journal:  BMC Cardiovasc Disord       Date:  2021-05-26       Impact factor: 2.298

4.  Validation of the Short-Form Health Literacy Questionnaire (HLS-SF12) and Its Determinants among People Living in Rural Areas in Vietnam.

Authors:  Tuyen Van Duong; Thao T P Nguyen; Khue M Pham; Kien T Nguyen; Manh H Giap; Tung D X Tran; Chi X Nguyen; Shwu-Huey Yang; Chien-Tien Su
Journal:  Int J Environ Res Public Health       Date:  2019-09-11       Impact factor: 3.390

5.  Associated Factors of Hypertension in Women and Men in Vietnam: A Cross-Sectional Study.

Authors:  Tran Quoc Cuong; Le Van Bao; Nguyen Anh Tuan; Vo Van Thang; Nguyen Minh Quan; Shwu-Huey Yang; Tuyen Van Duong
Journal:  Int J Environ Res Public Health       Date:  2019-11-26       Impact factor: 3.390

6.  Estimation of the cardiovascular risk using world health organization/international society of hypertension risk prediction charts in Central Vietnam.

Authors:  Ho Anh Hien; Nguyen Minh Tam; Vo Tam; Huynh Van Minh; Nguyen Phuong Hoa; Stefan Heytens; Anselme Derese; Dirk Devroey
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

Review 7.  Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in Nepal between 2000 and 2025: A Systematic Review and Meta-Analysis.

Authors:  Raja Ram Dhungana; Achyut Raj Pandey; Nipun Shrestha
Journal:  Int J Hypertens       Date:  2021-03-02       Impact factor: 2.420

8.  Type 2 diabetes and hypertension in Vietnam: a systematic review and meta-analysis of studies between 2000 and 2020.

Authors:  Tuhin Biswas; Nam Tran; Hoang Thi My Hanh; Pham Van Hien; Nguyen Thi Thu Cuc; Phan Hong Van; Khuong Anh Tuan; Tran Thi Mai Oanh; Abdullah Mamun
Journal:  BMJ Open       Date:  2022-08-08       Impact factor: 3.006

Review 9.  Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam.

Authors:  Dang Tran Dat; Nguyen Do Thi Ngoc Hien; Nguyen Nhu Quan; Mai Quoc Tung; Hoang Chi Tam; Bui Viet Hung
Journal:  J Clin Med       Date:  2022-08-10       Impact factor: 4.964

10.  Dietary Salt Reduction, Prevalence of Hypertension and Avoidable Burden of Stroke in Vietnam: Modelling the Health and Economic Impacts.

Authors:  Leopold Ndemnge Aminde; Hai N Phung; Dung Phung; Linda J Cobiac; J Lennert Veerman
Journal:  Front Public Health       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.